Atezolizumab in Combination with Bevacizumab for the Management of Patients with Hepatocellular Carcinoma in the First-Line Setting: Systematic Literature Review and Meta-Analysis

By sjmartinez • December 7, 2023

Vogel A, Finn RS, Blanchet Zumofen MH, Heuser C, Alvarez JS, Leibfried M, Mitchell CR, Batson S, Redhead G, Gaillard VE, Kudo M. Atezolizumab in Combination with Bevacizumab for the Management of Patients with Hepatocellular Carcinoma in the First-Line Setting: Systematic Literature Review and Meta-Analysis. Liver Cancer. 2023 Jul 29;12(6):510-520. doi: 10.1159/000533166. PMID: 38058419; PMCID: PMC10697759.

Tags: Atezolizumab, cancer immunotherapy, Hematology/Oncology, Hepatocellular carcinoma, Network meta-analysis, Publications

Predicting subjective sleepiness during auditory cognitive testing using voice signaling analysis

Te TT, Boland MR, Ghadimi S, Dzierzewski JM, Alessi C, Martin JL, Kremen S, Bui AAT, Naeim A, Fung CH. Predicting subjective sleepiness during auditory[...]

Feasibility of cognitive testing and ecological momentary assessments using smartphones in middle aged and older adults with insomnia

Ghadimi S, Ereso J, Kaula AJ, Taptiklis N, Cormack F, Alessi C, Martin JL, Dzierzewski JM, Naeim A, Kremen S, Te T, Fung CH. Feasibility[...]

A phase 2 trial of niraparib plus bevacizumab maintenance therapy following first-line platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: final analysis and overall survival results from OVARIO

Hardesty MM, Krivak TC, Wright GS, Hamilton E, Fleming EL, Belotte J, Gorman S, Compton N, Clements A, Gray HJ, Konecny GE, Moore RG, Richardson[...]